I In nt tr ro od du uc ct ti io on n: : Regulatory T cells (Tregs, CD4+CD25 high Foxp3 + ) play a crucial role in allergy and other inflammatory diseases. However, the isolation of viable Tregs on the basis of intracellular expression of specific Forkhead Box Protein P3 (Foxp3) is difficult. In this study we checked if the expression of IL-7 receptor (CD127) on the Tregs could be a useful marker for isolation of viable Treg Foxp3 + cells. M Ma at te er ri ia al l a an nd d m me et th ho od ds s: : Twenty-five patients sensitized to grass pollen with allergic rhinitis (AR) and ten healthy subjects were included. We compared Foxp3 expression in different CD4 + T cell subsets by flow cytometry and we assessed the relationship between the expression of Foxp3 and CD127 within regulatory T cells. R Re es su ul lt ts s: : Within the CD4 + lymphocytes 3.68 ±2.0% showed expression of Foxp3, 51.82 ±8.03% of CD4 + CD25 high were Foxp3 positive (Foxp3 + ), whereas 82.12 ±5.4% of CD4 + CD25 high CD127 low were Foxp3 + . High intracellular expression of Foxp3 correlated with low superficial CD127 expression (r = 0.42, p = 0.017). There were no significant differences regarding the analysed markers between AR patients and healthy controls. C Co on nc cl lu us si io on ns s: : Regulatory T cells may be purified from the fresh peripheral blood as viable regulatory Foxp3 bright cells using CD4, high expression of CD25 and low expression of CD127 antigen. K Ke ey y w wo or rd ds s: :
Introduction
Regulatory T CD4 cells (Tregs), expressing transcription factor Foxp3, play a critical role in the maintenance of immunological tolerance and control of autoimmunity and effectively suppress allergic inflammation. T CD4 + are a heterogeneous group of cells in phenotype and function [1] . It was demonstrated that CD25 is a crucial surface antigen for the regulatory T CD4 + subset, especially cells expressing the highest levels of CD25 (CD25 high ), which have suppressive activity [1, 2] . Furthermore, particularly the T CD4 + CD25 high subset includes transcription factor Foxp3, which plays a crucial role in suppressive and modulatory mechanisms [1, 2] .
Interleukin-7, which is constitutively produced especially by stromal cells from the thymus and bone marrow [3] , is essential for T lymphocyte development and function. It is crucial for the maturation and differenti-ation of memory CD4 + and CD8 + T cells and for the survival and homeostatic proliferation of naive T cells [4] . The biological effects of IL-7 are mediated via the IL-7 receptor (IL-7R, CD127). The receptor for IL-7 is expressed on naive T CD4 and CD8 cells, and memory CD4 + as well as CD8 + cells, but is downregulated on all human T cells after activation [4] .
In this study, we assessed the expression of Foxp3 separately in T CD4  + , T CD4  + CD25  high and T  CD4  + CD25 high CD127 low cells both in healthy and AR patients. We also assessed whether a low CD127 expression level correlates with higher expression of Foxp3 and if CD127 could be a useful additional marker for isolation of viable Tregs from the peripheral blood.
Material and methods

P Pa at ti ie en nt ts s
Thirty-five individuals (20 female, 15 male; 25 patients with allergic rhinitis and 10 healthy) were included in the study. Allergic rhinitis was diagnosed on the basis of a positive history, a skin prick test positive for grass pollen (mixture for five common grasses, Allergopharma ® , Reinbek, Germany), specific serum IgE for grass pollen (> 1.5 international units per millilitre (UniCap ® , Pharmacia & Upjohn, Diagnostics AB) and positive result of a conjunctival provocation test with grass pollen allergen extracts (Allergopharma ® , Reinbek, Germany). Patients suffering from persistent allergic rhinitis, asthma, upper respiratory tract infection during the 6 weeks preceding the study, neoplastic disease, autoimmunological disease (e.g. diabetes type I, systemic lupus erythematosus), current smokers, patients with tuberculosis, chronic sinusitis, systemic glucocorticosteroid treatment, immunosuppressive treatment, chronic obstructive pulmonary disease (COPD), heart failure, uncontrolled hypertension as well as pregnant and breast feeding women were all excluded from the study. In addition the healthy individuals included as a control were non-atopic and had no symptoms of allergy.
All patients discontinued their medications, including topical and oral antihistamines and topical corticosteroids, for at least 4 weeks before the visit.
The study was approved by the local Ethical Committee of the Medical University of Lodz and written informed consent was obtained from the patients.
Outside the pollen season, after the initial inclusion and exclusion criteria evaluation, a blood sample (20 ml) was drawn from all participants.
P Pe er ri ip ph he er ra al l b bl lo oo od d m mo on no on nu uc cl le ea ar r c ce el ll l p pr re ep pa ar ra at ti io on n Leukocytes were prepared from the whole blood anticoagulated with heparin. Blood samples (20 ml) were centrifuged (180 xg, 10 min, at room temperature) and the platelet rich plasma was removed.
The phase containing cells was collected and cells were suspended in RPMI-1640 medium 1 : 1 (SigmaAldrich ® , Poznań, Poland). The peripheral blood mononuclear leukocyte (PBML) fractions were obtained by density gradient centrifugation (460 xg, 30 min, at room temperature) over Ficoll-Paque (GE Medical Systems ® , Warsaw, Poland). The interphase containing PBMLs was collected and suspended in RPMI-1640 medium (up to 15 ml). Samples were centrifuged (400 xg, 10 min, at room temperature) then supernatant was removed and cells were suspended in 1 ml of RPMI-1640 medium. Cells were counted and the density of this suspension was assessed.
F Fl lo ow w c cy yt to om me et tr ry y S St ta at ti is st ti ic ca al l a an na al ly ys si is s Data were expressed as mean ± standard error of means (SEM) unless otherwise stated. To assess normality we used the Kolmogorov-Smirnov test. To compare between the AR and healthy group for normally distributed data unpaired t-test whereas for non-parametric data Mann-Whitney tests were used. When more than 2 groups were compared, ANOVA test was used. To assess correlations Spearman test was applied. A p < 0.05 was regarded as statistically significant. Statistica 5.1 PL for Windows software (StatSoft Polska ® , Cracow, Poland) was used for analyses.
Results
The study population included 25 rhinitic, nonasthmatic patients (18 with allergic rhinitis (AR), 7 with AR and allergic conjunctivitis) and 10 healthy subjects as a control group. Sensitization to grass pollen was confirmed with skin prick tests, conjunctival provocation tests and specific IgE for grass allergens in the serum. None of the patients had clinically relevant sensitization to perennial allergens. Detailed characteristics of subjects participating in the study are presented in Table I .
The PBMCs of healthy control and AR patients were stained with fluorescent labelled Abs directed against CD4, CD25, CD127 and Foxp3 and analysed by means of flow cytometry (Figure 1 high subset of T cells where the CD127 expression level was low (82.12 ±5.4%). There were no significant differences regarding the analysed markers between AR patients and healthy controls (Table II, Figure 2 ).
In addition, low expression of CD127 correlated (r = 0.42, p = 0.017) (Figure 3) 
CD25
+ regulatory T cell development and cause severe immunodysregulation, polyendocrinopathy, and enteropathy X-linked syndrome (IPEX) [1, 5, 6, 9] . As a marker of regulatory T cells, Foxp3 is useful to characterise preserved Tregs or to confirm the yield and purity of isolated Tregs. However, Foxp3 staining requires fixation and permeabilisation which facilitate the penetration of molecules into the cells; therefore, it is not suitable for isolating viable Tregs. Today, superficial markers usually used for Treg identification are CD4, CD25, CTLA-4, CD45 RO/RA, and CD39 [1, 2, 5, 7] . However, some of these markers (e.g. cytotoxic T-lymphocyte antigen 4 [CTLA-4] or glucocorticoid-induced tumour necrosis factor receptor [GITR]) are also expressed on effector T cells, which creates a problem in Treg immunophenotyping and isolation. Recently, Groth et al. [10] and Bluestone et al. [11] demonstrated that CD127 (receptor for IL-7)
V Va ar ri ia ab bl le e P Pa at ti ie en nt ts s w wi it th h a al ll le er rg gi ic c r rh hi in ni it ti is s H He ea al lt th hy y c co on nt tr ro ol ls s is downregulated on all human T cells after activation and, in contrast with the reported re-expression of CD127 on the majority of peripheral memory and effector T cells, Treg CD4 + CD25 high
Foxp3
+ cells remain CD127 low [11, 12] . Constitutively reduced expression of CD127 in Tregs may result from the Foxp3 interaction with the CD127 promoter that reduces expression of CD127 in this subset [11] . On the other hand, Foxp3 induced by activation in effector T cells is not sufficient to permanently suppress CD127 expression in these cells and after the initial, postactivation decline of CD127 expression in Teff cells CD127 is reconstituted [12] .
In this study we have stained PBMCs to identify CD4 [11] . Additionally, they indicated that low CD127 expression correlates inversely with high intracellular Foxp3 expression and CD127 may be a helpful superficial marker for Treg identification and for viable cell isolation [11] . What is more, Tregs isolated on the basis of CD25 + CD127 low expression displayed all the characteristics of regulatory T cells (expression of Foxp3, CTLA-4, hypoproliferation and ability to suppress proliferation of other T cells) [11] . In our study 86% of CD4 + CD25 high cells were CD127 low and low expression of CD127 corre lated with high Foxp3 coexpression. Similarly, in another study [13] 
